立场陈述:韩国的绝经后骨质疏松症治疗策略
So Young Park1, Se Hwa Kim2, Young-Kyun Lee3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
Journal of bone metabolism
|December 11, 2023
概括
本研究概述了基于骨折风险的骨质疏松症治疗策略. 它建议对高风险患者使用双酸盐或登苏马布,对非常高风险患者使用类固醇药物,并每年重新评估.
科学领域:
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
- 类风湿病学 类风湿病学
背景情况:
- 有效的骨质疏松症管理需要准确的骨折风险评估和量身定制的治疗策略.
- 韩国骨和矿物研究学会为绝经后骨质疏松症治疗提供了指导方针.
研究的目的:
- 提出关于绝经后骨质疏松症适当治疗策略的立场声明.
- 将患者分为骨折风险组,并推相应的治疗方法.
主要方法:
- 骨折风险分层基于先前的骨折,骨矿物密度 (BMD),风险评估工具和临床因素.
- 将其分为低,中等,高和非常高风险组.
- 每年重新评估骨折风险,以指导治疗调整.
主要成果:
- 高风险组:用双酸盐 (BPs) 或德诺苏玛布进行一线治疗;在德诺苏玛布后进行连续的BP治疗以防止反弹.
- 非常高风险群体:第一线治疗与合成药物 (teriparatide或romosozumab);连续的抗吸收疗法,以保持收益.
- 治疗计划每年根据重新评估的骨折风险进行调整.
结论:
- 基于风险的治疗算法对于有效的骨质疏松症管理至关重要.
- 对于不同类别的骨折风险,建议使用特定的药物治疗.
- 持续监测和治疗适应对于优化骨质疏松症的结果至关重要.
相关概念视频
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Menopause
170
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
170
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95


